Risks to the Returns to Medical Innovation: The Case of Myriad Genetics

Jeffrey Clemens and Stan Veuger

No 21469, NBER Working Papers from National Bureau of Economic Research, Inc

Abstract: We describe the broad range of uncertainties faced by the developers of medical technologies. Empirically, we estimate the asset market incidence of two realizations of uncertainties we classify as within-market policy risks. The events we analyze concern the intellectual property of Myriad Genetics, Inc., an American molecular diagnostics firm. In June 2013, the Supreme Court invalidated several of Myriad's intellectual property claims. Subsequently, the Center for Medicare and Medicaid Services (CMS) re-evaluated the reimbursements it pays for the services at issue in the Supreme Court's ruling. Each of these events moved Myriad's market capitalization by several hundred million dollars, or on the order of 20 percent. Myriad's exposure to the realization of these events reflected the concentration of its revenue streams among the affected services. We discuss the implications of the risks we analyze for the total volume of medical innovation and for its organization across firms.

JEL-codes: H51 H57 I18 O31 O32 O34 (search for similar items in EconPapers)
Date: 2015-08
New Economics Papers: this item is included in nep-ger, nep-hea, nep-ino, nep-ipr and nep-pr~
Note: EH PR
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published as Jeffrey Clemens & Stan Veuger, 2016. "RISKS TO THE RETURNS TO MEDICAL INNOVATION: THE CASE OF MYRIAD GENETICS," Contemporary Economic Policy, .

Downloads: (external link)
http://www.nber.org/papers/w21469.pdf (application/pdf)

Related works:
Journal Article: RISKS TO THE RETURNS TO MEDICAL INNOVATION: THE CASE OF MYRIAD GENETICS (2017)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:21469

Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w21469

Access Statistics for this paper

More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().